Risk of chronary heart disease in HIV-infected patients

Vitalii B. Kaliberdenko , Victoria S. Beter , Emilia R. Zagidullina , Tatiana S. Pronkina

For citation:

Abstract

This article examines the impact of cardiovascular diseases on the course of HIV and mortality. The risk of developing cardiovascular diseases (CVD) is associated with gender and virological and immunological status. Modifiable and non-modifiable risk factors are an integral part of the development of cardiovascular diseases, and in the context of existing HIV disease, new risk factors associated with the processes occurring in the immune system are added. Antiretroviral therapy drugs have side effects that affect the cardiovascular system. Existing methods of preventing and prognosticating CVD do not take into account new risk factors associated with HIV infection, which complicates the process of risk reduction.
Keywords: human immunodeficiency virus, cardiovascular diseases, coronary heart disease, risk factors, epidemiology

References

1. Neuhaus J, Angus B, Kowalska JD et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS 2010;24(5):697-706. DOI: 10.1097/QAD.0b013e3283365356
2. Mocroft A, Reiss P, Gasiorowski J et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010;55(2):262-70. DOI: 10.1097/QAI.0b013e3181e9be6b
3. Crum-Cianflone NF, Grandits G, Echols S et al. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr 2010;54(3):248-57. DOI: 10.1097/qai.0b013 e3181c8ef22
4. Чанахчян Ф.Н., Гуляев Н.И., Иванов Д.С., Новикова Е.А. ВИЧ-ассоциированные механизмы структурно-функциональных нарушений миокарда. Кардиология: новости, мнения, обучение. 2024;12(1):36-43. DOI: 10.33029/2309-1908-2024-12-1-36-43
Chanakhchyan F.N., Gulyaev N.I., Ivanov D.S., Novikova E.A. HIV-associated mechanisms of structural and functional disorders of the myocardium. Cardiology: news, opinions, training. 2024;12(1):36-43. DOI: 10.33029/2309-1908-2024-12-1-36-43 (in Russian).
5. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50(10):1387-96. DOI: 10.1086/652283
6. Marin B, Thiebaut R, Bucher HC et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. Aids 2009;23(13):1743-53. DOI: 10.1097/QAD.0b013e32832e9b78
7. Bonnet F, Chene G, Thiebaut R et al. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004. HIV Med 2007;8(8):547-54. DOI: 10.1111/j.1468-1293.2007.00508.x
8. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013;382(9903):1525-33. DOI: 10.1016/S0140-6736(13)61809-7
9. Аржакова М.А., Шеховцова Т.А., Дупляков Д.В. Ишемическая болезнь сердца у ВИЧ-инфицированных пациентов. Рациональная фармакотерапия в кардиологии 2019;15(6):900-5. DOI: 10.20996/1819-6446-2019-15-6-900-905
Arzhakova M.A., Shekhovtsova T.A., Duplyakov D.V. Coronary artery disease in HIV-infected patients. Rational Pharmacotherapy in Cardiology 2019;15(6):900-5. DOI: 10.20996/1819-6446-2019-15-6-900-905 (in Russian).
10. Шеховцова Т.А., Дупляков Д.В. ВИЧ-инфекция и патология сердечно-сосудистой системы. Кардиоваскулярная терапия и профилактика. 2023;22(3):3370. DOI: 10.15829/1728-8800-2023-3370
Shekhovtsova T.A., Duplyakov D.V. HIV infection and pathology of the cardiovascular system. Cardiovascular therapy and prevention. 2023;22(3):3370. DOI: 10.15829/1728-8800-2023-3370 (in Russian).
11. Горячева О.Г., Козиолова Н.А., Терехина Н.А. ВИЧ-ассоциированная патология сердечно-сосудистой системы. Российский кардиологический журнал. 2019;24(11):148-54 DOI: 10.15829/1560-4071-2019-11-148-154
Goryacheva O.G., Koziolova N.A., Terekhina N.A. HIV-associated pathology of the cardiovascular system. Russian Journal of Cardiology. 2019;24(11):148-54 DOI: 10.15829/1560-4071-2019-11-148-154 (in Russian).
12. Trickey A, May MT, Vehreschild J et al. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy. PLoS One 2016; 11(8):e0160460.
13. Feinstein MJ, Bahiru E, Achenbach C et al. Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013. Am J Cardiol 2016; 117(2):214-20.
14. Hatleberg CI, Ryom L, El-Sadr W et al. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS 2016; 30(10):1583-96.
15. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002; 30(5):471-7.
16. Currier JS, Taylor A, Boyd F et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003; 33(4):506-12.
17. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. JCEM 2007; 92(7):2506-12.
18. Протасов К.В., Енисеева Е.С., Плотникова Ю.К. Инфаркт миокарда у пациентов с ВИЧ-инфекцией: заболеваемость, факторы риска, особенности патогенеза, клиники и лечения. Российский кардиологический журнал. 2024;29(1S):567. DOI: 10.15829/1560-4071-2024-5670.
Protasov K.V., Yeniseeva E.S., Plotnikova Yu.K. Myocardial infarction in patients with HIV infection: morbidity, risk factors, features of pathogenesis, clinic and treatment. Russian Journal of Cardiology. 2024;29(1S):567. DOI: 10.15829/1560-4071-2024-5670 (in Russian).
19. Lang S, Mary-Krause M, Cotte L et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS 2010;24(8):1228-30.
20. Durand M, Sheehy O, Baril JG et al. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database. J Acquir Immune Defic Syndr 2011; 57(3):245-53.
21. Freiberg MS, Chang CC, Kuller LH et al. HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine 2013; 173(8):614-22.
22. Silverberg MJ, Leyden WA, Xu L et al. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr 2014; 65(2): 160-6
23. Lichtenstein KA, Armon C, Buchacz K et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51(4):435-47.
24. Achhra AC, Amin J, Law MG et al. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS 2010;24(12):1877-86. DOI: 10.1097/QAD. 0b013e32833b1b26
25. Morlat P, Roussillon C, Henard S et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS 2014;28(8):1181-91. DOI: 10.1097/QAD.0000000000000222
26. Smith CJ, Ryom L, Weber R et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014;384(9939):241–8. DOI: 10.1016/S0140-6736(14) 60604-8
27. Obel N, Thomsen HF, Kronborg G et al. Ischemic heart disease in HIV-infected and HIVuninfected individuals: a population-based cohort study. Clin Infect Dis 2007; 44(12):1625-31.
28. Schouten J, Wit FW, Stolte IG et al. Cross-sectional comparison of the prevalence of ageassociated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis 2014;59(12):1787-97. DOI: 10.1093/cid/ciu701

Портал CON-MED.RU:
https://con-med.ru/magazines/klinicheskiy_razbor_v_obshchey_meditsine/klinicheskiy_razbor_v_obshchey_meditsine-03-2025/risk_vozniknoveniya_ishemicheskoy_bolezni_serdtsa_u_patsientov_s_vich_infektsiey/

For citation: Kaliberdenko V.B., Beter V.S., Zagidullina E.R., Pronkina T.S. Risk of chronary heart disease in HIV-infected patients. Clinical review for general practice. 2025; 6 (3): 66–71 (In Russ.). DOI: 10.47407/kr2024.6.3.00583

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice